Onychomycosis: modern diagnostic and treatment approaches
Summary The medical term onychomycosis should be understood as chronic infection of the nails caused by a fungus. The most common causative agents are the dermatophytes and Candida species. The less common are certain types of moulds (nondermatophyte moulds or NDMs). In approximately 60–80 % of the...
Gespeichert in:
Veröffentlicht in: | Wiener medizinische Wochenschrift 2013, Vol.163 (1-2), p.1-12 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 12 |
---|---|
container_issue | 1-2 |
container_start_page | 1 |
container_title | Wiener medizinische Wochenschrift |
container_volume | 163 |
creator | Tchernev, Georgi Penev, Plamen Kolev Nenoff, Pietro Zisova, Liliya Georgieva Cardoso, José Carlos Taneva, Teodora Ginter-Hanselmayer, Gabriele Ananiev, Julian Gulubova, Maya Hristova, Reni Nocheva, Desislava Guarneri, Claudio Martino, G. Kanazawa, Nobuo |
description | Summary
The medical term onychomycosis should be understood as chronic infection of the nails caused by a fungus. The most common causative agents are the dermatophytes and
Candida
species. The less common are certain types of moulds (nondermatophyte moulds or NDMs). In approximately 60–80 % of the cases, onychomycosis is due to dermatophytes. Among dermatophytes, the most often isolated causative pathogen is
Trichophyton (T.) rubrum
. Other common species are
T. interdigitale
(formerly
T. mentagrophytes
),
Epidermophyton floccosum
, and
T. tonsurans
. The most significant yeasts causing onychomycosis are
Candida albicans
and
Candida parapsilosis
. Predisposing factors for onychomycosis include mainly diseases such as diabetes mellitus, peripheral vascular arterial disease, chronic venous insufficiency, polyneuropathies of diverse etiologies, and immunosuppression, e.g., myeloproliferative diseases (such as lymphoma and paraproteinemia), HIV/AIDS, etc. Other factors facilitating the fungal infection are frequent trauma in professional sportsmen, often accompanied by excessive perspiration. The diagnostic methods that are often applied in different dermatologic departments and ambulatory units are also different. This precludes the creation of a unified diagnostic algorithm that could be used everywhere as a possible standard. In most of the cases, the method of choice depends on the specialist’s individual experience. The therapeutic approach depends mostly on the fungal organism identified by the dermatologist or mycologist. This review hereby includes the conventional as well as the newest and most reliable and modern methods used for the identification of the pathogens causing onychomycosis. Moreover, detailed information is suggested, about the choice of therapeutic scheme in case whether dermatophytes, moulds, or yeasts have been identified as causative agents. A thorough discussion of the schemes and duration of the antifungal therapy in certain groups of patients have been included. |
doi_str_mv | 10.1007/s10354-012-0139-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1318689040</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1318689040</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-ce39c354c475ea186b6cce8cdadb7599ac09de44f9b6cbca1ca2e90deec50ebb3</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqXwA1hQRpbAObabmA0hvqRKXUBis5zztU3VOMVOhv57XLUwMpw83HPvnR_GrjnccYDyPnIQSubAi1RC5-KEjbmairxQ1dcpGwNIkSsh-YhdxLgG4KVWxTkbFQKUSOCY6bnf4aprd9jFJj5kbeco-Mw1dum72DeYWe-yPpDtW_J9Zrfb0FlcUbxkZwu7iXR1fCfs8-X54-ktn81f358eZzkKKfscSWhMV6IsFVleTespIlXorKtLpbVF0I6kXOjUqNFytAVpcESogOpaTNjtITct_h4o9qZtItJmYz11QzRcpNBKg4SE8gOKoYsx0MJsQ9PasDMczN6YORgzyZjZGzMizdwc44e6Jfc38asoAcUBiKnllxTMuhuCT1_-J_UHJ8R38w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1318689040</pqid></control><display><type>article</type><title>Onychomycosis: modern diagnostic and treatment approaches</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Tchernev, Georgi ; Penev, Plamen Kolev ; Nenoff, Pietro ; Zisova, Liliya Georgieva ; Cardoso, José Carlos ; Taneva, Teodora ; Ginter-Hanselmayer, Gabriele ; Ananiev, Julian ; Gulubova, Maya ; Hristova, Reni ; Nocheva, Desislava ; Guarneri, Claudio ; Martino, G. ; Kanazawa, Nobuo</creator><creatorcontrib>Tchernev, Georgi ; Penev, Plamen Kolev ; Nenoff, Pietro ; Zisova, Liliya Georgieva ; Cardoso, José Carlos ; Taneva, Teodora ; Ginter-Hanselmayer, Gabriele ; Ananiev, Julian ; Gulubova, Maya ; Hristova, Reni ; Nocheva, Desislava ; Guarneri, Claudio ; Martino, G. ; Kanazawa, Nobuo</creatorcontrib><description>Summary
The medical term onychomycosis should be understood as chronic infection of the nails caused by a fungus. The most common causative agents are the dermatophytes and
Candida
species. The less common are certain types of moulds (nondermatophyte moulds or NDMs). In approximately 60–80 % of the cases, onychomycosis is due to dermatophytes. Among dermatophytes, the most often isolated causative pathogen is
Trichophyton (T.) rubrum
. Other common species are
T. interdigitale
(formerly
T. mentagrophytes
),
Epidermophyton floccosum
, and
T. tonsurans
. The most significant yeasts causing onychomycosis are
Candida albicans
and
Candida parapsilosis
. Predisposing factors for onychomycosis include mainly diseases such as diabetes mellitus, peripheral vascular arterial disease, chronic venous insufficiency, polyneuropathies of diverse etiologies, and immunosuppression, e.g., myeloproliferative diseases (such as lymphoma and paraproteinemia), HIV/AIDS, etc. Other factors facilitating the fungal infection are frequent trauma in professional sportsmen, often accompanied by excessive perspiration. The diagnostic methods that are often applied in different dermatologic departments and ambulatory units are also different. This precludes the creation of a unified diagnostic algorithm that could be used everywhere as a possible standard. In most of the cases, the method of choice depends on the specialist’s individual experience. The therapeutic approach depends mostly on the fungal organism identified by the dermatologist or mycologist. This review hereby includes the conventional as well as the newest and most reliable and modern methods used for the identification of the pathogens causing onychomycosis. Moreover, detailed information is suggested, about the choice of therapeutic scheme in case whether dermatophytes, moulds, or yeasts have been identified as causative agents. A thorough discussion of the schemes and duration of the antifungal therapy in certain groups of patients have been included.</description><identifier>ISSN: 0043-5341</identifier><identifier>EISSN: 1563-258X</identifier><identifier>DOI: 10.1007/s10354-012-0139-3</identifier><identifier>PMID: 23053563</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Antifungal Agents - therapeutic use ; Candidiasis - diagnosis ; Candidiasis - drug therapy ; Combined Modality Therapy ; Dermatomycoses - diagnosis ; Dermatomycoses - drug therapy ; DNA, Fungal - analysis ; Enzyme-Linked Immunosorbent Assay ; Family Medicine ; Fluconazole - therapeutic use ; General Practice ; Geriatrics/Gerontology ; Humans ; Infectious Diseases ; Internal Medicine ; Itraconazole - therapeutic use ; Lasers, Solid-State - therapeutic use ; Low-Level Light Therapy ; Medicine ; Medicine & Public Health ; Naphthalenes - therapeutic use ; Onychomycosis - diagnosis ; Onychomycosis - drug therapy ; Opportunistic Infections - diagnosis ; Opportunistic Infections - drug therapy ; Pharmacology/Toxicology ; Polymerase Chain Reaction ; Review ; Risk Factors ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Tinea - diagnosis ; Tinea - drug therapy</subject><ispartof>Wiener medizinische Wochenschrift, 2013, Vol.163 (1-2), p.1-12</ispartof><rights>Springer-Verlag Wien 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-ce39c354c475ea186b6cce8cdadb7599ac09de44f9b6cbca1ca2e90deec50ebb3</citedby><cites>FETCH-LOGICAL-c344t-ce39c354c475ea186b6cce8cdadb7599ac09de44f9b6cbca1ca2e90deec50ebb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10354-012-0139-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10354-012-0139-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23053563$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tchernev, Georgi</creatorcontrib><creatorcontrib>Penev, Plamen Kolev</creatorcontrib><creatorcontrib>Nenoff, Pietro</creatorcontrib><creatorcontrib>Zisova, Liliya Georgieva</creatorcontrib><creatorcontrib>Cardoso, José Carlos</creatorcontrib><creatorcontrib>Taneva, Teodora</creatorcontrib><creatorcontrib>Ginter-Hanselmayer, Gabriele</creatorcontrib><creatorcontrib>Ananiev, Julian</creatorcontrib><creatorcontrib>Gulubova, Maya</creatorcontrib><creatorcontrib>Hristova, Reni</creatorcontrib><creatorcontrib>Nocheva, Desislava</creatorcontrib><creatorcontrib>Guarneri, Claudio</creatorcontrib><creatorcontrib>Martino, G.</creatorcontrib><creatorcontrib>Kanazawa, Nobuo</creatorcontrib><title>Onychomycosis: modern diagnostic and treatment approaches</title><title>Wiener medizinische Wochenschrift</title><addtitle>Wien Med Wochenschr</addtitle><addtitle>Wien Med Wochenschr</addtitle><description>Summary
The medical term onychomycosis should be understood as chronic infection of the nails caused by a fungus. The most common causative agents are the dermatophytes and
Candida
species. The less common are certain types of moulds (nondermatophyte moulds or NDMs). In approximately 60–80 % of the cases, onychomycosis is due to dermatophytes. Among dermatophytes, the most often isolated causative pathogen is
Trichophyton (T.) rubrum
. Other common species are
T. interdigitale
(formerly
T. mentagrophytes
),
Epidermophyton floccosum
, and
T. tonsurans
. The most significant yeasts causing onychomycosis are
Candida albicans
and
Candida parapsilosis
. Predisposing factors for onychomycosis include mainly diseases such as diabetes mellitus, peripheral vascular arterial disease, chronic venous insufficiency, polyneuropathies of diverse etiologies, and immunosuppression, e.g., myeloproliferative diseases (such as lymphoma and paraproteinemia), HIV/AIDS, etc. Other factors facilitating the fungal infection are frequent trauma in professional sportsmen, often accompanied by excessive perspiration. The diagnostic methods that are often applied in different dermatologic departments and ambulatory units are also different. This precludes the creation of a unified diagnostic algorithm that could be used everywhere as a possible standard. In most of the cases, the method of choice depends on the specialist’s individual experience. The therapeutic approach depends mostly on the fungal organism identified by the dermatologist or mycologist. This review hereby includes the conventional as well as the newest and most reliable and modern methods used for the identification of the pathogens causing onychomycosis. Moreover, detailed information is suggested, about the choice of therapeutic scheme in case whether dermatophytes, moulds, or yeasts have been identified as causative agents. A thorough discussion of the schemes and duration of the antifungal therapy in certain groups of patients have been included.</description><subject>Antifungal Agents - therapeutic use</subject><subject>Candidiasis - diagnosis</subject><subject>Candidiasis - drug therapy</subject><subject>Combined Modality Therapy</subject><subject>Dermatomycoses - diagnosis</subject><subject>Dermatomycoses - drug therapy</subject><subject>DNA, Fungal - analysis</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Family Medicine</subject><subject>Fluconazole - therapeutic use</subject><subject>General Practice</subject><subject>Geriatrics/Gerontology</subject><subject>Humans</subject><subject>Infectious Diseases</subject><subject>Internal Medicine</subject><subject>Itraconazole - therapeutic use</subject><subject>Lasers, Solid-State - therapeutic use</subject><subject>Low-Level Light Therapy</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Naphthalenes - therapeutic use</subject><subject>Onychomycosis - diagnosis</subject><subject>Onychomycosis - drug therapy</subject><subject>Opportunistic Infections - diagnosis</subject><subject>Opportunistic Infections - drug therapy</subject><subject>Pharmacology/Toxicology</subject><subject>Polymerase Chain Reaction</subject><subject>Review</subject><subject>Risk Factors</subject><subject>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</subject><subject>Tinea - diagnosis</subject><subject>Tinea - drug therapy</subject><issn>0043-5341</issn><issn>1563-258X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAQhi0EoqXwA1hQRpbAObabmA0hvqRKXUBis5zztU3VOMVOhv57XLUwMpw83HPvnR_GrjnccYDyPnIQSubAi1RC5-KEjbmairxQ1dcpGwNIkSsh-YhdxLgG4KVWxTkbFQKUSOCY6bnf4aprd9jFJj5kbeco-Mw1dum72DeYWe-yPpDtW_J9Zrfb0FlcUbxkZwu7iXR1fCfs8-X54-ktn81f358eZzkKKfscSWhMV6IsFVleTespIlXorKtLpbVF0I6kXOjUqNFytAVpcESogOpaTNjtITct_h4o9qZtItJmYz11QzRcpNBKg4SE8gOKoYsx0MJsQ9PasDMczN6YORgzyZjZGzMizdwc44e6Jfc38asoAcUBiKnllxTMuhuCT1_-J_UHJ8R38w</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Tchernev, Georgi</creator><creator>Penev, Plamen Kolev</creator><creator>Nenoff, Pietro</creator><creator>Zisova, Liliya Georgieva</creator><creator>Cardoso, José Carlos</creator><creator>Taneva, Teodora</creator><creator>Ginter-Hanselmayer, Gabriele</creator><creator>Ananiev, Julian</creator><creator>Gulubova, Maya</creator><creator>Hristova, Reni</creator><creator>Nocheva, Desislava</creator><creator>Guarneri, Claudio</creator><creator>Martino, G.</creator><creator>Kanazawa, Nobuo</creator><general>Springer Vienna</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2013</creationdate><title>Onychomycosis: modern diagnostic and treatment approaches</title><author>Tchernev, Georgi ; Penev, Plamen Kolev ; Nenoff, Pietro ; Zisova, Liliya Georgieva ; Cardoso, José Carlos ; Taneva, Teodora ; Ginter-Hanselmayer, Gabriele ; Ananiev, Julian ; Gulubova, Maya ; Hristova, Reni ; Nocheva, Desislava ; Guarneri, Claudio ; Martino, G. ; Kanazawa, Nobuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-ce39c354c475ea186b6cce8cdadb7599ac09de44f9b6cbca1ca2e90deec50ebb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antifungal Agents - therapeutic use</topic><topic>Candidiasis - diagnosis</topic><topic>Candidiasis - drug therapy</topic><topic>Combined Modality Therapy</topic><topic>Dermatomycoses - diagnosis</topic><topic>Dermatomycoses - drug therapy</topic><topic>DNA, Fungal - analysis</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Family Medicine</topic><topic>Fluconazole - therapeutic use</topic><topic>General Practice</topic><topic>Geriatrics/Gerontology</topic><topic>Humans</topic><topic>Infectious Diseases</topic><topic>Internal Medicine</topic><topic>Itraconazole - therapeutic use</topic><topic>Lasers, Solid-State - therapeutic use</topic><topic>Low-Level Light Therapy</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Naphthalenes - therapeutic use</topic><topic>Onychomycosis - diagnosis</topic><topic>Onychomycosis - drug therapy</topic><topic>Opportunistic Infections - diagnosis</topic><topic>Opportunistic Infections - drug therapy</topic><topic>Pharmacology/Toxicology</topic><topic>Polymerase Chain Reaction</topic><topic>Review</topic><topic>Risk Factors</topic><topic>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</topic><topic>Tinea - diagnosis</topic><topic>Tinea - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tchernev, Georgi</creatorcontrib><creatorcontrib>Penev, Plamen Kolev</creatorcontrib><creatorcontrib>Nenoff, Pietro</creatorcontrib><creatorcontrib>Zisova, Liliya Georgieva</creatorcontrib><creatorcontrib>Cardoso, José Carlos</creatorcontrib><creatorcontrib>Taneva, Teodora</creatorcontrib><creatorcontrib>Ginter-Hanselmayer, Gabriele</creatorcontrib><creatorcontrib>Ananiev, Julian</creatorcontrib><creatorcontrib>Gulubova, Maya</creatorcontrib><creatorcontrib>Hristova, Reni</creatorcontrib><creatorcontrib>Nocheva, Desislava</creatorcontrib><creatorcontrib>Guarneri, Claudio</creatorcontrib><creatorcontrib>Martino, G.</creatorcontrib><creatorcontrib>Kanazawa, Nobuo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Wiener medizinische Wochenschrift</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tchernev, Georgi</au><au>Penev, Plamen Kolev</au><au>Nenoff, Pietro</au><au>Zisova, Liliya Georgieva</au><au>Cardoso, José Carlos</au><au>Taneva, Teodora</au><au>Ginter-Hanselmayer, Gabriele</au><au>Ananiev, Julian</au><au>Gulubova, Maya</au><au>Hristova, Reni</au><au>Nocheva, Desislava</au><au>Guarneri, Claudio</au><au>Martino, G.</au><au>Kanazawa, Nobuo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Onychomycosis: modern diagnostic and treatment approaches</atitle><jtitle>Wiener medizinische Wochenschrift</jtitle><stitle>Wien Med Wochenschr</stitle><addtitle>Wien Med Wochenschr</addtitle><date>2013</date><risdate>2013</risdate><volume>163</volume><issue>1-2</issue><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>0043-5341</issn><eissn>1563-258X</eissn><abstract>Summary
The medical term onychomycosis should be understood as chronic infection of the nails caused by a fungus. The most common causative agents are the dermatophytes and
Candida
species. The less common are certain types of moulds (nondermatophyte moulds or NDMs). In approximately 60–80 % of the cases, onychomycosis is due to dermatophytes. Among dermatophytes, the most often isolated causative pathogen is
Trichophyton (T.) rubrum
. Other common species are
T. interdigitale
(formerly
T. mentagrophytes
),
Epidermophyton floccosum
, and
T. tonsurans
. The most significant yeasts causing onychomycosis are
Candida albicans
and
Candida parapsilosis
. Predisposing factors for onychomycosis include mainly diseases such as diabetes mellitus, peripheral vascular arterial disease, chronic venous insufficiency, polyneuropathies of diverse etiologies, and immunosuppression, e.g., myeloproliferative diseases (such as lymphoma and paraproteinemia), HIV/AIDS, etc. Other factors facilitating the fungal infection are frequent trauma in professional sportsmen, often accompanied by excessive perspiration. The diagnostic methods that are often applied in different dermatologic departments and ambulatory units are also different. This precludes the creation of a unified diagnostic algorithm that could be used everywhere as a possible standard. In most of the cases, the method of choice depends on the specialist’s individual experience. The therapeutic approach depends mostly on the fungal organism identified by the dermatologist or mycologist. This review hereby includes the conventional as well as the newest and most reliable and modern methods used for the identification of the pathogens causing onychomycosis. Moreover, detailed information is suggested, about the choice of therapeutic scheme in case whether dermatophytes, moulds, or yeasts have been identified as causative agents. A thorough discussion of the schemes and duration of the antifungal therapy in certain groups of patients have been included.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><pmid>23053563</pmid><doi>10.1007/s10354-012-0139-3</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0043-5341 |
ispartof | Wiener medizinische Wochenschrift, 2013, Vol.163 (1-2), p.1-12 |
issn | 0043-5341 1563-258X |
language | eng |
recordid | cdi_proquest_miscellaneous_1318689040 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Antifungal Agents - therapeutic use Candidiasis - diagnosis Candidiasis - drug therapy Combined Modality Therapy Dermatomycoses - diagnosis Dermatomycoses - drug therapy DNA, Fungal - analysis Enzyme-Linked Immunosorbent Assay Family Medicine Fluconazole - therapeutic use General Practice Geriatrics/Gerontology Humans Infectious Diseases Internal Medicine Itraconazole - therapeutic use Lasers, Solid-State - therapeutic use Low-Level Light Therapy Medicine Medicine & Public Health Naphthalenes - therapeutic use Onychomycosis - diagnosis Onychomycosis - drug therapy Opportunistic Infections - diagnosis Opportunistic Infections - drug therapy Pharmacology/Toxicology Polymerase Chain Reaction Review Risk Factors Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Tinea - diagnosis Tinea - drug therapy |
title | Onychomycosis: modern diagnostic and treatment approaches |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A52%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Onychomycosis:%20modern%20diagnostic%20and%20treatment%20approaches&rft.jtitle=Wiener%20medizinische%20Wochenschrift&rft.au=Tchernev,%20Georgi&rft.date=2013&rft.volume=163&rft.issue=1-2&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=0043-5341&rft.eissn=1563-258X&rft_id=info:doi/10.1007/s10354-012-0139-3&rft_dat=%3Cproquest_cross%3E1318689040%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1318689040&rft_id=info:pmid/23053563&rfr_iscdi=true |